Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic

Br J Haematol. 2020 Jun;189(6):e224-e227. doi: 10.1111/bjh.16782. Epub 2020 May 23.

Authors

John Willan^{1

2}, Andrew J King³, Faouzi Djebbari², Gareth D H Turner⁴, Daniel J Royston⁴, Sue Pavord², Graham P Collins², Andy Peniket²

Affiliations

¹ Department of Haematology, Frimley Health NHS Foundation Trust, Slough, Berkshire, UK.
² Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Headington, Oxford, UK.
³ Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
⁴ Department of Cellular Pathology and Nuffield Division of Clinical Laboratory Sciences, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.

PMID: 32369622
DOI: 10.1111/bjh.16782

No abstract available

Publication types

Letter

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections* / epidemiology
Coronavirus Infections* / therapy
Female
Hematologic Neoplasms* / epidemiology
Hematologic Neoplasms* / therapy
Hematologic Neoplasms* / virology
Humans
Leukemia, Myeloid, Acute* / epidemiology
Leukemia, Myeloid, Acute* / therapy
Leukemia, Myeloid, Acute* / virology
Male
Myelodysplastic Syndromes* / epidemiology
Myelodysplastic Syndromes* / therapy
Myelodysplastic Syndromes* / virology
Pandemics*
Pneumonia, Viral* / epidemiology
Pneumonia, Viral* / therapy
SARS-CoV-2